Nautilus Biotechnology Stock Investor Sentiment

NAUT Stock  USD 1.00  0.04  4.17%   
Slightly above 56% of all Nautilus Biotechnology's private investors are looking to take a long position. The analysis of the overall investor sentiment regarding Nautilus Biotechnology suggests that some traders are interested. Nautilus Biotechnology's investing sentiment can be driven by a variety of factors including economic data, Nautilus Biotechnology's earnings reports, geopolitical events, and overall market trends.
  
2 days ago at www.macroaxis.com         
Acquisition by Murphy Matthew B. of 160000 shares of Nautilus Biotechnology at 1.24 subject to Rule ...
Macroaxis News
few days ago at www.macroaxis.com         
Acquisition by Nazem Farzad of 45000 shares of Nautilus Biotechnology at 2.56 subject to Rule 16b-3
Macroaxis News
six days ago at www.macroaxis.com         
Acquisition by Akinsanya Karen of 14411 shares of Nautilus Biotechnology subject to Rule 16b-3
Macroaxis News
over a week ago at www.macroaxis.com         
Acquisition by Nelson Nicholas A. of 160000 shares of Nautilus Biotechnology at 1.24 subject to Rule...
Macroaxis News
over two weeks ago at insidermonkey.com         
Nautilus Biotechnology, Inc. Q4 2024 Earnings Call Transcript
insidermonkey News
over two weeks ago at insidermonkey.com         
Acquisition by Subra Sankar of 160000 shares of Nautilus Biotechnology at 1.24 subject to Rule 16b-3
insidermonkey News
over two weeks ago at gurufocus.com         
Q4 2024 Nautilus Biotechnology Inc Earnings Call Transcript
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Nautilus Biotechnology Inc Q4 2024 Earnings Call Highlights Progress in Proteome ...
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Nautilus Biotechnology Inc Q4 2024 Earnings Call Highlights Progress in Proteome ...
Yahoo News
over two weeks ago at seekingalpha.com         
Nautilus Biotechnology beats Q4 profit estimates, issues outlook
seekingalpha News
over two weeks ago at gurufocus.com         
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference
Gurufocus Stories at Macroaxis
over a month ago at news.google.com         
Nautilus Biotechnology, Inc. Sees Significant Drop in Short Interest - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Nautilus Biotechnology Trading Down 5.9 percent - Heres Why - MarketBeat
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 2...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Nautilus Biotechnology that are available to investors today. That information is available publicly through Nautilus media outlets and privately through word of mouth or via Nautilus internal channels. However, regardless of the origin, that massive amount of Nautilus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nautilus Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nautilus Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nautilus Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nautilus Biotechnology alpha.

Nautilus Biotechnology Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Nautilus Stock Analysis

When running Nautilus Biotechnology's price analysis, check to measure Nautilus Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nautilus Biotechnology is operating at the current time. Most of Nautilus Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nautilus Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nautilus Biotechnology's price. Additionally, you may evaluate how the addition of Nautilus Biotechnology to your portfolios can decrease your overall portfolio volatility.